Updates and Late Breaking News Webinar

Description

Join this webinar to get excited about attending Excipient World this May! We have an exciting line-up of guest speakers including Francis Godwin (FDA) who will share new details about what to expect at the event.

In addition, we will allow extra time to answer your questions about:
> Travel and venue
> Networking opportunities
> Education program
> Exhibit hall

Questions are welcome and encouraged as they come up during the webinar. In the meantime, please feel free to email advance questions to Courtney@ExcipientWorld.org.

Who should attend?
Anyone who is still on the fence about attending Excipient World 2023... including people from the following areas:
> Regulatory Affairs
> Research & Development
> Product Development
> Formulation
> Commercial Management
> Government Affairs
> Purchasing and Supply Chain
> Quality Assurance

Contributors

Nigel Langley PhD MBA

Chair, IPEC-Americas

Nigel Langley provides technical support to the pharmaceutical industry and helps solve drug formulation challenges. He has held various senior technical and marketing positions during his career. Nigel has also worked in Japan and England with Croda International prior to joining BASF. He gained his Chemistry (Hons) degree and PhD (Liquid Crystals) from the University of Hull (UK) and an MBA from Leeds University (UK). He also took a 2 -year Postdoctoral research position at Leeds University (UK) in natural product synthesis. He has over 100 scientific publications and has co-edited 2 books. Nigel is an adjunct professor at the University of Mississippi and a Fellow of the Royal Society of Chemistry (UK). In 2018 he was awarded the Industry Research Achievement Award in Excipient Technology by the IPEC Foundation. He has been a member of the Executive Committee at IPEC Americas since 2010 and is currently the Chair of the organization. He is also helping to lead the Novel Excipients initiative for IPEC-Americas in collaboration with the IQ Pharma Consortium. Nigel is on the Medicine Maker’s Power List for 2020 and 2021 for small molecules.
Francis Godwin

Office Director
OMQ | OC | CDER | FDA

Francis Godwin received his undergraduate degree from MIT in Chemical Engineering in 2001. After graduation he worked as a process engineer designing, building, and optimizing chemical plants. He was certified as a Black Belt in Six Sigma performing quality improvement projects and teaching Six Sigma principals. He then worked in pharmaceutical process validation for both batch and continuous processes for APIs and finished dosage manufacturing operations. Later, he managed an analytical chemistry laboratory conducting analyses for production, QA, and research testing. In 2009 he received an MBA from Georgetown University and since then, has been working at FDA in CDER's Office of Compliance. He has served in various functions within compliance, and is currently the Director of the Office of Manufacturing Quality, overseeing regulatory and enforcement actions for both foreign and domestic drug CGMP cases.
Priscilla Zawislak

Global Regulatory Affairs Advocacy Manager
IFF

Priscilla Zawislak has over 35 years’ experience in regulatory affairs and quality for excipients, food additives and ingredients for personal care products. She is a past Chair of IPEC-Americas and is the current President of the IPEC Federation. Priscilla is the Global Regulatory Affairs Advocacy Manager for IFF.
Jennifer Putnam

R&D Senior Supervisor
Perrigo

Jennifer Putnam is a Senior Supervisor, Analytical R&D at Perrigo. She leads a team of scientists responsible for raw material characterization and evaluation in support of alternate source qualification and impact assessment of supplier changes for materials used in the products manufactured at Perrigo’s Michigan, USA sites, primarily solid and liquid oral generic drug products. Jennifer received a B.S. in Chemistry from Saginaw Valley State University. She is currently the Vice Chair of IPEC-Americas Compendial Review/Harmonization Committee.
Katherine Ulman

KLU Consulting, LLC
Katherine Ulman retired from Dow Corning Corporation, now a wholly owned subsidiary of The Dow Chemical Company, after more than 40 years of employment. There she held positions as a global regulatory compliance manager for their healthcare business as well as regulatory manager of the Dow Corning Healthcare Industries Materials Site.

Description

Contributors

Nigel Langley PhD MBA

Francis Godwin

Priscilla Zawislak

Jennifer Putnam

Katherine Ulman